Cargando…

Clinical and molecular characteristics of East Asian patients with von Hippel–Lindau syndrome

BACKGROUND: Von Hippel–Lindau (VHL) syndrome is a dominantly inherited multisystem cancer syndrome caused by a heterozygous mutation in the VHL tumor suppressor gene. Previous studies suggested that similar populations of Caucasian and Japanese patients have similar genotype or phenotype characteris...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Meihua, Chu, Ying-Hsia, Tan, Hwei Ling, Bessho, Hideharu, Ngeow, Joanne, Tang, Tiffany, Tan, Min-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986176/
https://www.ncbi.nlm.nih.gov/pubmed/27527340
http://dx.doi.org/10.1186/s40880-016-0141-z
_version_ 1782448159890341888
author Wong, Meihua
Chu, Ying-Hsia
Tan, Hwei Ling
Bessho, Hideharu
Ngeow, Joanne
Tang, Tiffany
Tan, Min-Han
author_facet Wong, Meihua
Chu, Ying-Hsia
Tan, Hwei Ling
Bessho, Hideharu
Ngeow, Joanne
Tang, Tiffany
Tan, Min-Han
author_sort Wong, Meihua
collection PubMed
description BACKGROUND: Von Hippel–Lindau (VHL) syndrome is a dominantly inherited multisystem cancer syndrome caused by a heterozygous mutation in the VHL tumor suppressor gene. Previous studies suggested that similar populations of Caucasian and Japanese patients have similar genotype or phenotype characteristics. In this comprehensive study of East Asian patients, we investigated the genetic and clinical characteristics of patients with VHL syndrome. METHODS: To create a registry of clinical characteristics and mutations reported in East Asian patients with VHL syndrome, we conducted a comprehensive review of English language and non-English language articles identified through a literature search. Publications in Japanese or Chinese language were read by native speakers of the language, who then performed the data extraction. RESULTS: Of 237 East Asian patients with VHL syndrome, 154 unique kindreds were identified for analysis. Analyzed by kindred, missense mutations were the most common (40.9%, 63/154), followed by large/complete deletions (32.5%, 50/154) and nonsense mutations (11.7%, 18/154). Compared with a previously reported study of both East Asian and non-East Asian patients, we found several key differences. First, missense and frameshift mutations in the VHL gene occurred less commonly in our population of East Asian patients (40.9% vs. 52.0%; P = 0.012 and 8.4% vs. 13.0%; P < 0.001, respectively). Second, large/complete deletions were more common in our population of East Asian patients (32.5% vs. 10.5%; P < 0.001). Third, phenotypically, we observed that, in our population of East Asian patients with VHL syndrome, the incidence of retinal capillary hemangioblastoma was lower, whereas the incidence of renal cell carcinoma was higher. CONCLUSIONS: Evidence suggests that the genotypic and phenotypic characteristics of East Asian patients with VHL syndrome differ from other populations. This should be considered when making screening recommendations for VHL syndrome in Asia. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40880-016-0141-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4986176
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49861762016-08-22 Clinical and molecular characteristics of East Asian patients with von Hippel–Lindau syndrome Wong, Meihua Chu, Ying-Hsia Tan, Hwei Ling Bessho, Hideharu Ngeow, Joanne Tang, Tiffany Tan, Min-Han Chin J Cancer Original Article BACKGROUND: Von Hippel–Lindau (VHL) syndrome is a dominantly inherited multisystem cancer syndrome caused by a heterozygous mutation in the VHL tumor suppressor gene. Previous studies suggested that similar populations of Caucasian and Japanese patients have similar genotype or phenotype characteristics. In this comprehensive study of East Asian patients, we investigated the genetic and clinical characteristics of patients with VHL syndrome. METHODS: To create a registry of clinical characteristics and mutations reported in East Asian patients with VHL syndrome, we conducted a comprehensive review of English language and non-English language articles identified through a literature search. Publications in Japanese or Chinese language were read by native speakers of the language, who then performed the data extraction. RESULTS: Of 237 East Asian patients with VHL syndrome, 154 unique kindreds were identified for analysis. Analyzed by kindred, missense mutations were the most common (40.9%, 63/154), followed by large/complete deletions (32.5%, 50/154) and nonsense mutations (11.7%, 18/154). Compared with a previously reported study of both East Asian and non-East Asian patients, we found several key differences. First, missense and frameshift mutations in the VHL gene occurred less commonly in our population of East Asian patients (40.9% vs. 52.0%; P = 0.012 and 8.4% vs. 13.0%; P < 0.001, respectively). Second, large/complete deletions were more common in our population of East Asian patients (32.5% vs. 10.5%; P < 0.001). Third, phenotypically, we observed that, in our population of East Asian patients with VHL syndrome, the incidence of retinal capillary hemangioblastoma was lower, whereas the incidence of renal cell carcinoma was higher. CONCLUSIONS: Evidence suggests that the genotypic and phenotypic characteristics of East Asian patients with VHL syndrome differ from other populations. This should be considered when making screening recommendations for VHL syndrome in Asia. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40880-016-0141-z) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-15 /pmc/articles/PMC4986176/ /pubmed/27527340 http://dx.doi.org/10.1186/s40880-016-0141-z Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Article
Wong, Meihua
Chu, Ying-Hsia
Tan, Hwei Ling
Bessho, Hideharu
Ngeow, Joanne
Tang, Tiffany
Tan, Min-Han
Clinical and molecular characteristics of East Asian patients with von Hippel–Lindau syndrome
title Clinical and molecular characteristics of East Asian patients with von Hippel–Lindau syndrome
title_full Clinical and molecular characteristics of East Asian patients with von Hippel–Lindau syndrome
title_fullStr Clinical and molecular characteristics of East Asian patients with von Hippel–Lindau syndrome
title_full_unstemmed Clinical and molecular characteristics of East Asian patients with von Hippel–Lindau syndrome
title_short Clinical and molecular characteristics of East Asian patients with von Hippel–Lindau syndrome
title_sort clinical and molecular characteristics of east asian patients with von hippel–lindau syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986176/
https://www.ncbi.nlm.nih.gov/pubmed/27527340
http://dx.doi.org/10.1186/s40880-016-0141-z
work_keys_str_mv AT wongmeihua clinicalandmolecularcharacteristicsofeastasianpatientswithvonhippellindausyndrome
AT chuyinghsia clinicalandmolecularcharacteristicsofeastasianpatientswithvonhippellindausyndrome
AT tanhweiling clinicalandmolecularcharacteristicsofeastasianpatientswithvonhippellindausyndrome
AT besshohideharu clinicalandmolecularcharacteristicsofeastasianpatientswithvonhippellindausyndrome
AT ngeowjoanne clinicalandmolecularcharacteristicsofeastasianpatientswithvonhippellindausyndrome
AT tangtiffany clinicalandmolecularcharacteristicsofeastasianpatientswithvonhippellindausyndrome
AT tanminhan clinicalandmolecularcharacteristicsofeastasianpatientswithvonhippellindausyndrome